CLINICAL TRIALS PROFILE FOR BUPROPION HYDROBROMIDE
✉ Email this page to a colleague
All Clinical Trials for BUPROPION HYDROBROMIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02129751 ↗ | Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder | Not yet recruiting | Bausch Health Americas, Inc. | Phase 4 | 2021-11-01 | Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety |
NCT02129751 ↗ | Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder | Not yet recruiting | Valeant Pharmaceuticals International, Inc. | Phase 4 | 2021-11-01 | Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety |
NCT02860962 ↗ | A Trial of Dextromethorphan for Treatment of Major Depressive Disorder | Completed | Medical University of South Carolina | Phase 1 | 2016-08-01 | A proof-of-concept study to determine the antidepressant potential of Dextromethorphan for treating depression associated with Major Depressive Disorder in inpatients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BUPROPION HYDROBROMIDE
Condition Name
Clinical Trial Locations for BUPROPION HYDROBROMIDE
Trials by Country
Clinical Trial Progress for BUPROPION HYDROBROMIDE
Clinical Trial Phase
Clinical Trial Sponsors for BUPROPION HYDROBROMIDE
Sponsor Name